LMB-2

DRUG3 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Adult T-Cell Leukemia (ATL)ChronicCutaneousLeukemiaLymphocyticLymphomaT-Cell

Phase 1

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

CompletedNCT00924170

National Cancer Institute (NCI)Adult T-Cell Leukemia (ATL)

Start: 2008-10-31End: 2021-05-05Updated: 2023-11-14

Phase 2

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Chronic Lymphocytic Leukemia

CompletedNCT00077922

National Cancer Institute (NCI)Chronic, Leukemia, Lymphocytic

Start: 2004-02-29End: 2011-12-31Updated: 2018-01-23

Anti-Tac(Fv)-PE38 (LMB-2) to Treat Cutaneous T-Cell Lymphomas

CompletedNCT00080535

National Cancer Institute (NCI)Cutaneous, Lymphoma, T-Cell

Start: 2004-04-30End: 2011-12-31Updated: 2018-01-29